New Early Access to Medicines Scheme
Under new Regulations, severely ill patients and those with rare debilitating conditions could be given new medicines years before they are licensed. The idea is to help patients in England with severe illnesses who have no other treatment options. The Medicines and Healthcare Products Regulatory Agency (MHRA) will oversee the Early Access to Medicines scheme …